InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.23
(
0.77%
)
US TECH 100
19,409.60
(
1.26%
)
Dow Jones
38,778.10
(
0.49%
)
Brent Oil
83.62
(
-0.34%
)
Bitcoin
65,434.01
(
-1.58%
)
Post# of 417
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

joe_techi

Send PM Follow Ignore
Followers 32
Posts 3279
Boards Moderated 0
Alias Born 08/31/2006

joe_techi

Re: None

Tuesday, 10/14/2014 10:43:55 AM

Tuesday, October 14, 2014 10:43:55 AM

Post# of 417
NVLX $0.21 - Nuvilex, Inc. (otcqb:NVLX) has officially introduced its advanced pancreatic cancer treatment to the U.S. Food and Drug Administration (FDA) in an application asking the agency to grant orphan drug status to its Cell-in-a-Box®/ifosfamide combination for the rare disease.
http://www.marketwatch.com/story/nuvilexs-cancer-treatment-obtaining-fda-orphan-drug-status-would-make-company-attractive-big-pharma-target-2014-10-14
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up